Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study-Reference-Cited by-同舟云学术

Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study

Published:2006-05 Issue:1 Volume:186 Page:222-224
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Eiriksdottir Gudny,Aspelund Thor,Bjarnadottir Kristjana,Olafsdottir Elin,Launer Lenore J.,Harris Tamara B.,Gudnason Vilmundur

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference7 articles.

1. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease;Danesh;N Engl J Med,2004

2. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans;Austin;Ann Hum Genet,2004

3. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals;Judson;Atherosclerosis,2004

4. Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men;Manttari;Atherosclerosis,2001

5. Association of apolipoprotein E polymorphism with plasma levels of high density lipoprotein and lipoprotein(a), and effect of diet in healthy men and women;Gudnason;Nutr Metabol Cardiovasc Dis,1993

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Physical frailty;Aging;2023

3. Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management;Chonnam Medical Journal;2023

4. Social network and the risk for developing mild cognitive impairment and dementia among older adults;Aging Clinical and Experimental Research;2022-06-10

5. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer’s disease in healthy samples across the lifespan;Brain, Behavior, and Immunity;2022-02